Lazard Asset Management’s Avita Medical RCEL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15K | Buy |
+2,973
| New | +$15K | ﹤0.01% | 2142 |
|
2025
Q1 | – | Sell |
-1,142
| Closed | -$14K | – | 2530 |
|
2024
Q4 | $14K | Buy |
1,142
+1,014
| +792% | +$12.4K | ﹤0.01% | 2091 |
|
2024
Q3 | $1K | Buy |
+128
| New | +$1K | ﹤0.01% | 2197 |
|
2024
Q2 | – | Sell |
-5,428
| Closed | -$87K | – | 2393 |
|
2024
Q1 | $87K | Sell |
5,428
-388
| -7% | -$6.22K | ﹤0.01% | 1582 |
|
2023
Q4 | $79K | Buy |
5,816
+406
| +8% | +$5.52K | ﹤0.01% | 1755 |
|
2023
Q3 | $79K | Hold |
5,410
| – | – | ﹤0.01% | 1710 |
|
2023
Q2 | $92K | Buy |
5,410
+2,643
| +96% | +$44.9K | ﹤0.01% | 1610 |
|
2023
Q1 | $38K | Buy |
+2,767
| New | +$38K | ﹤0.01% | 1874 |
|
2021
Q4 | – | Sell |
-3,724
| Closed | -$65K | – | 2427 |
|
2021
Q3 | $65K | Buy |
+3,724
| New | +$65K | ﹤0.01% | 1567 |
|